Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2019 Oct;8(14):6176-6184.
doi: 10.1002/cam4.2546. Epub 2019 Sep 5.

Efficacy and safety of different fractions in stereotactic body radiotherapy for spinal metastases: A systematic review

Yining Gong  1 , Lingyi Xu  2 , Hongqing Zhuang  3 , Liang Jiang  1 , Feng Wei  1 , Zhongjun Liu  1 , Yan Li  1 , Miao Yu  1 , Kaiwen Ni  4 , Xiaoguang Liu  1
Affiliations
Meta-Analysis

Efficacy and safety of different fractions in stereotactic body radiotherapy for spinal metastases: A systematic review

Yining Gong et al. Cancer Med. 2019 Oct.

Abstract

Background: In the treatment of spinal metastases, stereotactic body radiotherapy (SBRT) delivers precise, high-dose radiation to the target region while sparing the spinal cord. A range of doses and fractions had been reported; however, the optimal prescribed scheme remains unclear.

Methods: Two reviewers performed independent literature searches of the PubMed, EMBASE, Cochrane Database, and Web of Science databases. Articles were divided into one to five fractions groups. The Methodological Index for Non-randomized Studies (MINORS) was used to assess the quality of studies. Local control (LC) and overall survival (OS) were presented for the included studies and a pooled value was calculated by the weighted average.

Results: The 38 included studies comprised 3,754 patients with 4,731 lesions. The average 1-year LCs for the one to five fractions were 92.7%, 84.6%, 86.8%, 82.6%, and 80.6%, respectively. The average 1-year OS for the one to five fractions were 53.0%, 70.4%, 60.1%, 48%, and 80%, respectively. The 24 Gy/single fraction scheme had a higher 1-year LC (98.1%) than those of 24 Gy/two fractions (85.4%), 27 Gy/three fractions (84.9%), and 24 Gy/three fractions (89.0%). The incidence of vertebral compression fracture was 10.3%, with 10.7% in the single-fraction group and 10.1% in the multi-fraction group. The incidence of radiation-induced myelopathy was 0.19%; three and two patients were treated with single-fraction and multi-fraction SBRT, respectively. The incidence of radiculopathy was 0.30% and all but one patient were treated with multi-fraction SBRT.

Conclusions: SBRT provided satisfactory efficacy and acceptable safety for spinal metastases. Single-fraction SBRT demonstrated a higher local control rate than those of the other factions, especially the 24 Gy dose. The risk of vertebral compression fracture (VCF) was slightly higher in single-fraction SBRT and more patients developed radiculopathy after multi-fraction SBRT.

Keywords: multi-fraction; single-fraction; spinal metastases; stereotactic body radiotherapy; stereotactic radiosurgery; systematic review.

PubMed Disclaimer

Conflict of interest statement

We declare that there is no conflict of interest to this work.

Figures

Figure 1
Figure 1
Flow of information through the different phases of the systematic review. SBRT, stereotactic body radiotherapy; SRS, stereotactic radiosurgery; LC, local control; OS, overall survival
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Anwar M, Barani IJ. Role of stereotactic body radiotherapy in spinal metastasis and subsequent fracture risk: identifying and treating the at‐risk patient. CNS Oncol. 2013;2:437‐445. - PMC - PubMed
    1. Witham TF, Khavkin YA, Gallia GL, Wolinsky J‐P, Gokaslan ZL. Surgery insight: current management of epidural spinal cord compression from metastatic spine disease. Nat Clin Pract Neurol. 2006;2:87‐94; quiz 116. - PubMed
    1. Klimo P Jr, Kestle JR, Schmidt MH. Clinical trials and evidence‐based medicine for metastatic spine disease. Neurosurg Clin N Am. 2004;15:549‐564. - PubMed
    1. Kumar N, Tan K‐A, Tan JH, et al. The influence of histologic subtype in predicting survival of lung cancer patients with spinal metastases. Clin Spine Surg. 2018;31:E1‐E7. - PubMed
    1. Rades D, Veninga T, Stalpers L, et al. Outcome after radiotherapy alone for metastatic spinal cord compression in patients with oligometastases. J Clin Oncol. 2007;25:50‐56. - PubMed

LinkOut - more resources